Title |
The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial |
|---|---|
Involved |
Johannes Weller (Verfasser)
Thomas Zeyen (Verfasser) Niklas Schäfer (Verfasser) Christina Schaub (Verfasser)
Anna-Laura Potthoff (Verfasser)
Joachim P. Steinbach (Verfasser) Peter Hau (Verfasser) Clemens Seidel (Verfasser) Roland Goldbrunner (Verfasser) Ghazaleh Tabatabai (Verfasser) Hartmut Vatter (Verfasser) Theophilos Tzaridis (Verfasser) Matthias Schneider (Verfasser) Ulrich Herrlinger (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
Journal of neuro-oncology 164, 3, 3.10.2023, date:9.2023, Seite 749-755 |
Published |
2023 |
Language |
|
Country |
|
Topic |
|
Subject |
Oncology. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2024010908095858557694 (URN) |
Record ID |
1315408759 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: